What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?

@inproceedings{Kent2015WhatIT,
  title={What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?},
  author={Seamus Kent and Iryna Schlackow and Jingky Lozano-K{\"u}hne and C Reith and Jonathan Robert Emberson and Richard J Haynes and Alastair M Gray and Alan Cass and Colin Baigent and Martin J Landray and William G. Herrington and Borislava Mihaylova},
  booktitle={BMC Nephrology},
  year={2015}
}
BackgroundReliable estimates of the impacts of chronic kidney disease (CKD) stage, with and without cardiovascular disease, on hospital costs are needed to inform health policy.MethodsThe Study of Heart and Renal Protection (SHARP) randomized trial prospectively collected information on kidney disease progression, serious adverse events and hospital care use in a cohort of patients with moderate-to-severe CKD. In a secondary analysis of SHARP data, the impact of participants’ CKD stage, non… CONTINUE READING
Highlighted Tweets
This paper has been referenced on Twitter 7 times. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES

Effect of chronic kidney disease and comorbid conditions on health care costs: a 10-year observational study in a general population

  • SE Baumeister, CA Boger, BK Kramer, A Doring, D Eheberg, B Fischer
  • Am J Nephrol
  • 2010
2 Excerpts